Illumina’s precarious acquisition of Grail could soon cost it dearly, with the Financial Timesreporting that it may be confronted with an enormous fine as early as next week in response to its decision to flout European regulators’ warnings.
Illumina Creeps Closer To Half-Billion-Dollar Fine
The sequencing giant could be pilloried in Europe and may have to pay a record-breaking fine.
